(AOF) – Virbac announces growth in its annual turnover of 4.9% “thanks to a record level of activity in the fourth quarter”. The animal health specialist posts 1.24 billion euros in turnover in 2023 after fourth quarter turnover of 321.7 million euros, up 9.1% year-on-year. The company reaffirms its objective of 2024 growth of between 4% and 6% with an adjusted Ebit to turnover ratio of “around 15%” at constant exchange rates, before 20% by 2030
In 2023, the ratio of “current operating income before depreciation of assets resulting from acquisitions” to “turnover” is still expected to be around 15% at constant exchange rates.
“Thanks to the dynamics of our petfood, specialties, dental and dermatology ranges which are achieving double-digit growth”, the companion animals segment grew by 10.9% in the fourth quarter at constant rates.
In the livestock segment, Virbac posted growth at constant rates of 12.5%: all of its ranges by species recorded “significant” progress, particularly the aquaculture and ruminant segments.
© 2024 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
